A fermented formula in pre-term infants: Clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory IgA

British Journal of Nutrition

Volumn 105, Issue 12, 2011, Pages 1843-1851

  Campeotto, Florence ^a,b,g   Suau, Antonia ^c   Kapel, Nathalie ^b,d   Magne, Fabien ^c   Viallon, Vivian ^e   Ferraris, Laurent ^b   Waligora Dupriet, Anne Judith ^b   Soulaines, Pascale ^a   Leroux, Bernard ^f   Kalach, Nicolas ^a   Dupont, Christophe ^a,g   Butel, Marie José ^b  

^a Université Paris Descartes ^*  (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Bioinformatique et Chimie Moléculaire   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f Néonatologie Unité Mère Enfant Alix de Champagne   (France)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Calprotectin; Fermented formula; Gut microbiota; Pre term infants; Secretory IgA

Indexed keywords

CALGRANULIN; SECRETORY IMMUNOGLOBULIN; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL DISTENSION; ARTICLE; ARTIFICIAL MILK; BACTERIAL COLONIZATION; BIFIDOBACTERIUM BREVE; CONTROLLED STUDY; DIGESTIVE FUNCTION; DOWN REGULATION; FECES ANALYSIS; FEMALE; FERMENTATION TECHNIQUE; FERMENTED PRODUCT; FOLLOW UP; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; IMMUNITY; INFANT; INFANT FEEDING; INFLAMMATION; INTENTION TO TREAT ANALYSIS; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; PREMATURITY; PROTEIN BLOOD LEVEL; STREPTOCOCCUS THERMOPHILUS; UPREGULATION;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM BREVE; STREPTOCOCCUS THERMOPHILUS;

EID: 79958767588     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114510005702     Document Type: Article

References (41)

1. Magne F, Abély M, Boyer F, et al. (2006) Low species diversity and high diversity variability in feces of preterm infants as revealed by 16s rDNA sequences and PCR-TTGE profiles. FEMS Microbiol Ecol 57, 128-138. (Pubitemid 43880249)
2. Szajewska H (2010) Probiotics and prebiotics in preterm infants: where are we? where are we going? Early Hum Dev 86, S81-S86.
3. Veereman-Wauters G (2005) Application of prebiotics in infant foods. Br J Nutr 93, Suppl. 1, S57-S60. (Pubitemid 43073408)
4. Alfaleh K, Anabrees J & Bassler D (2010) Probiotics reduce the risk of necrotizing enterocolitis in preterm infants: a meta-analysis. Neonatology 97, 93-99.
5. Deshpande G, Rao S, Patole S, et al. (2010) Updated metaanalysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 125, 921-930.
6. Agostoni C, Buonocore G, Carnielli VP, et al. (2010) Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastroenterol Nutr 50, 85-91.
7. Boyle RJ, Robins-Browne RM & Tang ML (2006) Probiotic use in clinical practice: what are the risks? Am J Clin Nutr 83, 1256-1264. (Pubitemid 44713053)
8. Ohishi A, Takahashi S, Ito Y, et al. (2010) Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele. J Pediatr 156, 679-681.
9. Roberfroid M (2007) Prebiotics: the concept revisited. J Nutr 137, 830S-837S. (Pubitemid 46397526)
10. Lomax AR & Calder PC (2009) Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans. Curr PharmDes 15, 1428-1518.
11. Srinivasjois R, Rao S & Patole S (2009) Prebiotic supplementation of formula in preterm neonates: a systematic review and meta-analysis of randomised controlled trials. Clin Nutr 28, 237-242.
12. Mihatsch WA, Hoegel J & Pohlandt F (2006) Prebiotic oligosaccharides reduce stool viscosity and accelerate gastrointestinal transport in preterm infants. Acta Paediatr 95, 843-848. (Pubitemid 44261744)
13. Westerbeek EA, van den Berg JP, Lafeber HN, et al. (2010) Neutral and acidic oligosaccharides in preterm infants: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 91, 679-686.
14. Agostoni C, Goulet O, Kolacek S, et al. (2007) Fermented infant formulae without live bacteria. J Pediatr Gastroenterol Nutr 44, 392-397. (Pubitemid 46673395)
15. Menard S, Candalh C, Ben AM, et al. (2006) Stimulation of immunity without alteration of oral tolerance in mice fed with heat-treated fermented infant formula. J Pediatr Gastroenterol Nutr 43, 451-458. (Pubitemid 44569004)
16. Hoarau C, Lagaraine C, Martin L, et al. (2006) Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a toll-like receptor 2 pathway. J Allergy Clin Immunol 117, 696-702. (Pubitemid 43340238)
17. Mullie C, Yazourh A, Thibault H, et al. (2004) Increased poliovirus-specific intestinal antibody response coincides with promotion of Bifidobacterium longum-infantis and Bifidobacterium breve in infants: a randomized, doubleblind, placebo-controlled trial. Pediatr Res 56, 791-795. (Pubitemid 39403407)
18. Thibault H, Aubert-Jacquin C & Goulet O (2004) Effects of long-term consumption of a fermented infant formula (with Bifidobacterium breve c50 and Streptococcus thermophilus 065) on acute diarrhea in healthy infants. J Pediatr Gastroenterol Nutr 39, 147-152.
19. Indrio F, Ladisa G, Mautone A, et al. (2007) Effect of a fermented formula on thymus size and stool pH in healthy term infants. Pediatr Res 62, 98-100. (Pubitemid 46985858)
20. Hay WW Jr (2008) Strategies for feeding the preterm infant. Neonatology 94, 245-254.
21. Rougé C, Goldenberg O, Ferraris L, et al. (2010) Investigation of the intestinal microbiota in preterm infants using different methods. Anaerobe 16, 362-370.
22. Butel MJ, Suau A, Campeotto F, et al. (2007) Conditions of bifidobacterial colonization in preterm infants: a prospective analysis. J Pediatr Gastroenterol Nutr 44, 577-582. (Pubitemid 46684358)
23. Magne F, Hachelaf W, Suau A, et al. (2006) A longitudinal study of infant faecal microbiota during weaning. FEMS Microbiol Ecol 58, 563-571. (Pubitemid 44748163)
24. Kapel N, Matarazzo P, Haouchine D, et al. (1999) Fecal tumor necrosis factor alpha, eosinophil cationic protein and IgE levels in infants with cow's milk allergy and gastrointestinal manifestations. Clin Chem Lab Med 37, 29-32. (Pubitemid 29097250)
25. Boehm G, Lidestri M, Casetta P, et al. (2002) Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants. Arch Dis Child Fetal Neonatal Ed 86, F178-F181. (Pubitemid 34478248)
26. Indrio F, Riezzo G, Raimondi F, et al. (2009) Prebiotics improve gastric motility and gastric electrical activity in preterm newborns. J Pediatr Gastroenterol Nutr 49, 258-261.
27. Underwood MA, Salzman NH, Bennett SH, et al. (2009) A randomized placebo-controlled comparison of 2 prebiotic/ probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids. J Pediatr Gastroenterol Nutr 48, 216-225.
28. Moro G, Minoli I, Mosca M, et al. (2002) Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formulafed term infants. J Pediatr Gastroenterol Nutr 34, 291-295. (Pubitemid 34437523)
29. Waligora-Dupriet AJ, Dugay A, Auzeil N, et al. (2005) Evidence for clostridial implication in necrotizing enterocolitis through bacterial fermentation in a gnotobiotic quail model. Pediatr Res 58, 629-635. (Pubitemid 41368888)
30. De La Cochetière MF, Piloquet H, Des Robert C, et al. (2004) Early intestinal bacterial colonization and necrotizing enterocolitis in premature infants: the putative role of Clostridium. Pediatr Res 56, 1-5.
31. Rougé C, Piloquet H, Butel MJ, et al. (2009) Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 89, 1828-1835.
32. Gewolb IH, Schwalbe RS, Taciak VL, et al. (1999) Stool microflora in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 80, F167-F173. (Pubitemid 29453033)
33. Schwiertz A, Gruhl B, Lobnitz M, et al. (2003) Development of the intestinal bacterial composition in hospitalized preterm infants in comparison with breast-fed, full-term infants. Pediatr Res 54, 393-399. (Pubitemid 37013203)
34. Roudiere L, Jacquot A, Marchandin H, et al. (2009) Optimized PCR-temporal temperature gel electrophoresis compared to cultivation to assess diversity of gut microbiota in neonates. J Microbiol Methods 79, 156-165.
35. Westerbeek EA, van den BA, Lafeber HN, et al. (2006) The intestinal bacterial colonisation in preterm infants: A review of the literature. Clin Nutr 25, 361-368. (Pubitemid 43843032)
36. Campeotto F, Kalach N, Lapillonne A, et al. (2007) Time course of faecal calprotectin in preterm newborns during the first month of life. Acta Paediatr 96, 1531-1533. (Pubitemid 47416431)
37. Campeotto F, Butel MJ, Kalach N, et al. (2004) High faecal calprotectin concentrations in newborns infants. Arch Dis Child Fetal Neonatal Ed 89, F353-F355. (Pubitemid 38869681)
38. Savino F, Castagno E, Calabrese R, et al. (2009) High faecal calprotectin levels in healthy, exclusively breast-fed infants. Neonatology 97, 299-304.
39. Rougé C, Butel MJ, Piloquet H, et al. (2010) Fecal calprotectin excretion in preterm infants during the neonatal period. PLoS One 5, e11083.
40. Yang Q, Smith PB, Goldberg RN, et al. (2008) Dynamic change of fecal calprotectin in very low birth weight infants during the first month of life. Neonatology 94, 267-271.
41. Mohan R, Koebnick C, Schildt J, et al. (2008) Effects of Bifidobacterium lactis supplementation on body weight, fecal pH, acetate, lactate, calprotectin and IgA in preterm infants. Pediatr Res 64, 418-422.